FUB-APINACA
Systematic (IUPAC) name | |
---|---|
N-(adamantan-1-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | |
Clinical data | |
Legal status |
|
Chemical data | |
Formula | C25H26FN3O |
Molar mass | 403.5 g/mol |
| |
|
FUB-APINACA (also known as FUB-AKB48) is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is an analogue of APINACA and 5F-APINACA where the pentyl chain has been replaced with fluorobenzyl.
Legal status
Sweden's public health agency suggested classifying FUB-APINACA as a hazardous substance on November 10, 2014.[2]
It is also illegal in Alabama (listed as FUB-AKB48).[3]
See also
References
- ↑ "FUB-AKB48". Cayman Chemical. Retrieved 23 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
- ↑ Alabama Senate Bill SB 333: Controlled Substances
This article is issued from Wikipedia - version of the Sunday, March 20, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.